PTCH1 and medulloblastoma: Brdu assay revealed that BBR dose-dependently inhibited the growth of medulloblastoma cell growth (Fig. 4a), concomitantly with comparable reduction of the mRNA expression of Gli1, and ptch1 (Fig. 4b, c), which served as a readout of the Hh pathway activity.